Literature DB >> 26459457

[The challenge of acute kidney injury : Cross-sectional study on prevalence and costs in a university intensive care unit].

I Göcze1, T Bergler2, E Bossauer3, F Zeman4, K Thelen5, B M Graf6, B Banas2, H J Schlitt5, W Gnann3, T Bein6.   

Abstract

BACKGROUND AND OBJECTIVES: The prognosis of intensive care patients with acute kidney injury (AKI), which is associated with increased mortality is still poor. Current data on the prevalence and the resulting costs of AKI and an overview of the most common diagnoses associated with AKI in German intensive care units (ICU) are lacking. PATIENTS AND METHODS: In this retrospective study all adult admissions (> 18 Jahre) in the five ICUs at the University Clinic Regensburg (in total 78 beds) from1 January 2011 to 31 December 2013 were evaluated. The ICU diagnoses commonly associated with AKI were identified using the international classification of diseases 10 (ICD 10). The length of ICU and hospital stays and AKI-associated hospital costs in the diagnosis-related groups (DRG) based reimbursement system were compared.
RESULTS: A total of 891 ICU patients with AKI were classified according to the ICD 10 code. Acute respiratory distress syndrome (ARDS), myocardial infarction (MI) and sepsis were the three most common ICU conditions associated with AKI. A total of 1103 patients were admitted with 1 of these 3 main diagnoses and 249 (22.6 %) of these patients developed AKI. Patients with AKI had significantly longer mean ICU and hospital stays compared to patients without AKI (18.6 vs 5.1 days and 23.8 vs. 10.4 days, respectively, p < 0.001). The presence of AKI in critically ill patients with ARDS, MI and sepsis resulted in additional costs of 2,019,120.42 € at the University Hospital of Regensburg in 2013.
CONCLUSION: Acute kidney injury in critically ill patients represents a significant medical and socioeconomic burden. Early recognition of patients at risk, coordinated research into novel interventions and establishment of the National Acute Kidney Injury Network for implementation of evidence-based therapies may be the next steps to decrease the incidence and severity of AKI and save costs for the national healthcare system.

Entities:  

Keywords:  Acute respiratory distress syndrome; Early diagnosis; Health care economics; Myocardial infarction; Sepsis

Mesh:

Year:  2015        PMID: 26459457     DOI: 10.1007/s00063-015-0093-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

1.  Fluid therapy and acute kidney injury in cardiogenic shock after cardiac arrest.

Authors:  Christoph Adler; Hannes Reuter; Catherine Seck; Martin Hellmich; Carsten Zobel
Journal:  Resuscitation       Date:  2012-06-30       Impact factor: 5.262

2.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.

Authors:  Somjot S Brar; Vicken Aharonian; Prakash Mansukhani; Naing Moore; Albert Y-J Shen; Michael Jorgensen; Aman Dua; Lindsay Short; Kevin Kane
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

3.  Ventilatory strategies in septic patients. Results from a nationwide observational trial.

Authors:  D Schädler; G Elke; C Engel; H Bogatsch; I Frerichs; R Kuhlen; R Rossaint; M Quintel; J Scholz; F M Brunkhorst; M Loeffler; K Reinhart; N Weiler
Journal:  Anaesthesist       Date:  2013-01-16       Impact factor: 1.041

4.  Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study.

Authors:  Geetha Balasubramanian; Ziyad Al-Aly; Abdul Moiz; Michael Rauchman; Zhiwei Zhang; Rajalakshmi Gopalakrishnan; Sumitra Balasubramanian; Tarek M El-Achkar
Journal:  Am J Kidney Dis       Date:  2010-12-31       Impact factor: 8.860

5.  Hospital-acquired acute kidney injury and hospital readmission: a cohort study.

Authors:  Ioannis Koulouridis; Lori Lyn Price; Nicolaos E Madias; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2014-10-22       Impact factor: 8.860

6.  Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

Authors:  Frank M Brunkhorst; Michael Oppert; Gernot Marx; Frank Bloos; Katrin Ludewig; Christian Putensen; Axel Nierhaus; Ulrich Jaschinski; Andreas Meier-Hellmann; Andreas Weyland; Matthias Gründling; Onnen Moerer; Reimer Riessen; Armin Seibel; Maximilian Ragaller; Markus W Büchler; Stefan John; Friedhelm Bach; Claudia Spies; Lorenz Reill; Harald Fritz; Michael Kiehntopf; Evelyn Kuhnt; Holger Bogatsch; Christoph Engel; Markus Loeffler; Marin H Kollef; Konrad Reinhart; Tobias Welte
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

Review 7.  Long-term outcomes of acute kidney injury.

Authors:  Ryan Goldberg; Paula Dennen
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

8.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Early acute kidney injury and sepsis: a multicentre evaluation.

Authors:  Sean M Bagshaw; Carol George; Rinaldo Bellomo
Journal:  Crit Care       Date:  2008-04-10       Impact factor: 9.097

10.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

View more
  1 in total

1.  Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.

Authors:  Fabian Dusse; Michaela Edayadiyil-Dudásova; Matthias Thielmann; Daniel Wendt; Philipp Kahlert; Ender Demircioglu; Heinz Jakob; Simon T Schaefer; Kevin Pilarczyk
Journal:  BMC Anesthesiol       Date:  2016-09-08       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.